Apt Therapeutics, Inc.
Records under this name other than the patents Apt Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 3 of 3 · Back to Apt Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,021,866 | Therapeutic Use of Adpase Enhanced Apyrases Term ended Term ended Sep 7, 2026 · High confidence | Term ended | Term ended Sep 7, 2026 | High confidence |
| US 7,390,485 | Design and Therapeutic Use of Adpase Enhanced Apyrases Term ended Term ended Jul 7, 2026 · High confidence | Term ended | Term ended Jul 7, 2026 | High confidence |
| US 7,247,300 | Therapeutic Use of Soluble CD39L3 Term ended Term ended Apr 21, 2025 · High confidence | Term ended | Term ended Apr 21, 2025 | High confidence |